Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Liberia

NCT01905436 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01905436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01905436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Liberia
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
July 31, 2021
Enrollment
21,862 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic filariasis, onchocerciasis, soil transmitted helminth (sth) infections